MALINC1 and breast carcinoma: Furthermore, the immune profiling described in our study suggests that high-MALINC1-overexpressing cells at pre-invasive and invasive stages are characterized by a tumor-associated immunosuppressive phenotype in luminal-like breast carcinomas.